Matthew David Hall, M.D., MBA, Installed as Endowed Chair in Pediatric Oncology at Baptist Health Herbert Wertheim Cancer Institute

• by

• September 23, 2026

Personalized Cancer Vaccine Linked to Three-Year Disease-Free Survival in Head and Neck Cancer

All 16 patients who received TG4050 after standard treatment remained disease-free, compared with 13 of 16 patients in the control group

• September 16, 2026

• 2 min

Comparing the utility of FDG PET-CT and contrast-enhanced CT in patients with oesophagogastric adenocarcinoma treated with neoadjuvant chemotherapy

• by J. L. Moore, M. Arora, C. Sit, R. Rahman, M. Green, H. Deere, J. Lagergren, S. Chicklore, F. Chinaka, N. Maisey, S. Ngan, A. Sita-Lumsden, A. Qureshi, K. Owczarczyk, W. R. C. Knight, M. Kelly, C. R. Baker, J. A. Gossage, M. Subesinghe, A. R. Davies

• September 17, 2026

Intraoperative Evaluation of Sarcoma Surgical Margins With Indocyanine Green Fluorescence Imaging: Results From an Observational Study

• by Sumail Bhogal, Matthew Gong, William Li, Brenda Diergaarde, Alma Heyl, Clark Roth, Lawrence Garvin, Alexander Hoffman, Amanda Locker, Ines Lohse, Maria Silvaggio, Stella Lee, Richard McGough, Kurt Weiss

• September 17, 2026